logo

For the Inventor, By the Inventor

Mumbai, India

Cipla Limited


USPTO Granted Patents = 179

% Expired Patents = 51.4



Trademarks = 13

Forward Citations = 498

Loading Chart...
Loading Chart...

87 inventors (with patents filed for the assignee):

goldMedal Dharmaraj Ramachandra Rao (87 out of 88 patents)

silverMedal Rajendra Narayanrao Kankan (85 out of 85 patents)

bronzeMedal Geena Malhotra (71 out of 79 patents)

4.  Amar Lulla (35 out of 38 patents)

5.  Srinivas Laxminarayan Pathi (30 out of 30 patents)

6.  Kalpana Sanjay Joshi (23 out of 38 patents)

7.  Manjinder Singh Phull (20 out of 20 patents)

8.  Xerxes Rao (16 out of 18 patents)

9.  Maruti Ganpati Ghagare (16 out of 16 patents)

10.  Jeevan Ghosalkar (14 out of 17 patents)

11.  Dilip Ramdas Birari (13 out of 13 patents)

12.  Sarabjit Singh (12 out of 14 patents)

13.  Manish Gopaldas Gangrade (8 out of 8 patents)

14.  Ravikumar Puppala (8 out of 8 patents)

15.  Shrinivas Madhukar Purandare (7 out of 7 patents)


Core Competencies:
Pharmaceutical Formulation
Intranasal Formulation
Depot Formulation
Antiviral Composition
Combination Therapy
Stable Formulations
Polymorphs
Rifaximin
Cancer Treatment
Hepatitis C
Adherence Tracking
Spirometer

179 patents:

1. 12703681 - Methods for the preparation of sphingosine 1-phosphate receptor modulators and solid forme thereof (2026-08-11),
2. 12558321 - Pharmaceutical formulation (2026-02-24),
3. 12472190 - Pharmaceutical compositions (2025-11-18),
4. 12384784 - Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor (2025-08-12),
5. 12324811 - Intranasal formulation (2025-06-10),
6. 12213798 - Adherence-tracking and monitoring device for metered-dose inhaler (2025-02-04),
7. 12195480 - Polymorphs of integrase inhibitor (2025-01-14),
8. 12109270 - Rifaximin complexes (2024-10-08),
9. 12109200 - Rifaximin (2024-10-08),
10. 12090163 - Pharmaceutical compositions (2024-09-17),
11. 12036358 - Single blister-strip based dispenser (2024-07-16),
12. 11931362 - Stable pharmaceutical formulations of pemetrexed (2024-03-19),
13. 11612612 - Pharmaceutical compositions (2023-03-28),
14. 11596597 - Depot formulation (2023-03-07),
15. 11478483 - Method of treating hypertension (2022-10-25),
Cipla Limited is a leading global pharmaceutical company headquartered in Mumbai, India. Founded in 1935, Cipla is dedicated to providing high-quality and affordable healthcare solutions worldwide. It primarily focuses on developing and manufacturing medicines for respiratory, cardiovascular, anti-infective, CNS, and other therapeutic segments. Cipla operates in over 80 countries and has a strong presence in both developed and emerging markets. Through innovative research and development, Cipla aims to make healthcare accessible to all.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Cipla Limited
179 Patents

#3 in Mumbai

#8 in India

#4,649 in the World

Mumbai, IN
Mumbai, India

Cipla Limited

Forward Citations = 498

87 inventors:

goldMedal Dharmaraj Ramachandra Rao (87 out of 88 patents)

silverMedal Rajendra Narayanrao Kankan (85 out of 85 patents)

bronzeMedal Geena Malhotra (71 out of 79 patents)

4.  Amar Lulla (35 out of 38 patents)

5.  Srinivas Laxminarayan Pathi (30 out of 30 patents)

Please report any incorrect information to [email protected]
Loading…